Erectile Dysfunction
The goal of this course is to explain how nurses can monitor and teach patients to safely use medications that selectively inhibit cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5), first-line treatment for erectile dysfunction.

Course Publication Date: March 14, 2018

This course is available with NO ADDITIONAL FEE if you have an active one year unlimited membership!

Author:Denise L. Gray RN, MAS, BSN, CCM
Course No:ED022318
Contact Hours:1.00
Delivery Method:Online Self Study
Category:Community & Home Health
Emergency & Trauma Medicine
Geriatric Medicine
Medical & Surgical Issues
Psychiatric & Mental Health
  

Ready to take a course?

  • Take as many courses as you want
  • Earn as many credits as you need
  • 100% Guaranteed
Buy One Year Unlimited Membership
Learning Objectives
  • Recognize examples of medications that selectively inhibit cGMP-specific phosphodiesterase type 5 (PDE5).
  • Identify possible drug interactions with cGMP-specific phosphodiesterase type 5 (PDE5) inhibitors.
  • Describe how nurses can monitor patients for possible adverse drug events resulting from cGMP-specific phosphodiesterase type 5 (PDE5) inhibitors.
  • Select information to teach patients taking cGMP-specific phosphodiesterase type 5 (PDE5) inhibitors.


 (394ms)
CPE-WEB01 18.212.83.37 url(WWW.MYFREECE.COM)-domain(WWW.MYFREECE.COM)-anon

Search Courses

Group Plan

Group plans are convenient and cost effective!

Authors Wanted


Earn $$$ as a MyFreeCE Author!